Search results

Selected filters:

Law & Policy
News

Article type

Topic

Sector

Regions

Year

324 results found for your search

Sort options
21 December 2018

Life sciences round-up - UK Supreme Court rules in landmark case, patent linkage shelved in China, big CAFC decision and much more

A summary of the major IP news from the biotechnology, pharmaceutical and medical technology sectors in November and the first-half of December

12 December 2018

Supreme Court of India set to rule in crucial plant innovation dispute

The decision in Monsanto’s appeal against the revocation of a key patent right could have profound implications on the ability to protect agro-biotech inventions in India

04 December 2018

All the action from the final day of IPBC Asia 2018

This year's event in Shanghai has now come to an end. It's been a great couple of days, including the IP Asia Elite Gala Dinner and Awards held last night

03 December 2018

IPBC Asia Day One report - all the highlights from another sell-out event

How Chinese courts will rule the patent world; Qualcomm's 5G licensing spree; don't jail trolls, says former supreme court judge; patent sales are on the up; plus a whole lot more from a wet, but spectacular, Shanghai Pudong

02 December 2018

Oppo’s big Nokia deal; pharma patents under pressure; Silicon Valley woe; patent market data revealed; plus much more

Your essential Sunday reading: a summary of all the stories posted on the IAM platform in the past week - as well as links to each one

30 November 2018

How a Chinese court would have decided the <em>Unwired Planet</em> appeal

Previous FRAND-related rulings indicate judges in China could set a global rate, would adopt the hard-edged non-discrimination obligation and would consider the parties' negotiation behaviours when reaching their decisions 

29 November 2018

OPINION: It's time to sort out the connected car disconnect

TCL v Ericsson and Unwired Planet v Huawei send two very different messages to auto companies being approached by patent pools such as Avanci to take SEP licences, says Unified Patents' chief IP counsel Jonathan Stroud 

26 November 2018

Pharma patent owners in the US are under pressure like they have never been before

Life sciences IP is on the front line as American consumers, legislators and the Trump administration kick back against the high cost of medicines. Reform campaigners say they have never been more confident of change.

25 November 2018

Patent sales on the rise; Microsoft’s deal with Chinese drone company; a deep dive into Oppo’s portfolio; IP insurance goes mainstream; and much more

Your essential Sunday reading: a summary of all the stories posted on the IAM platform in the past week - as well as links to each one

19 November 2018

Dosage patents come under scrutiny at UK Supreme Court

Justices today considering a much-anticipated case whose outcome could make it harder for pharma companies to obtain such protection in the future

15 November 2018

Congress needs role in key patent reform debates, says senior GOP legislator

Tipped to be the ranking Republican on the House Judiciary Committee, Doug Collins looks set to emerge as one of most powerful IP policy voices on Capitol Hill

15 November 2018

The big life sciences IP developments from October 2018

Cannabis patent war looming, “New NAFTA” set to benefit biopharma innovators, a blow for medical device inventors at the CJEU, and much more in this round-up of October’s big life sciences IP news

14 November 2018

UK Supreme Court rejects Warner-Lambert’s pregabalin appeal

Company now faces possibility of £500 million pay-out to the NHS, while ruling could also make second medical use patents harder to obtain and easier to invalidate

10 November 2018

Acting US Attorney General sat on board of Florida company that ran patent filing scam

Matthew Whitaker (right) allegedly sent intimidating emails to victims of World Patent Marketing, a firm that was shut down by the FTC and fined $26 million for cheating inventors.

09 November 2018

SEP owners must beware of hindering Europe's golden 5G opportunity

In an exclusive opinion piece for IAM, Jim Beveridge of the Innovators' Network argues that originators need to embrace transparency and avoid royalty stacking to allow IoT innovation to thrive